4.7 Article

Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants

期刊

DRUG DESIGN DEVELOPMENT AND THERAPY
卷 17, 期 -, 页码 2421-2429

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S409524

关键词

acetylsalicylic acid; salicylic acid; enteric -coated sustained -release; pharmacokinetics

向作者/读者索取更多资源

This study aimed to compare the pharmacokinetic characteristics of enteric-coated sustained-release (EcSr) aspirin tablets with enteric-coated (Ec) aspirin tablets in healthy Chinese participants. The results showed that EcSr aspirin tablets had less inter-individual variation in release and absorption, and meals had no significant effect on their pharmacokinetics.
Purpose: To study and compare the pharmacokinetic characteristics of enteric-coated sustained-release (EcSr) aspirin tablets with enteric-coated (Ec) aspirin tablets (Bayer S.p.A) in healthy Chinese participants.Patients and Methods: In this open, randomized, single-dose, three-way, crossover study, 18 healthy participants randomly received 100 mg EcSr tablets pre-prandially (a.c.), EcSr tablets post-prandially (p.c.), or Ec tablets a.c. in each period. The concentrations of acetylsalicylic acid (ASA) and salicylic acid (SA) in plasma were determined by the LC-MS/MS method, and the pharmacokinetic parameters were calculated using WinNonlin (version 8.1).Results: The essential PK parameters under the three treatment conditions (ie Ec a.c., EcSr a.c. and EcSr p.c.) were as follows: Cmax, ASA: 758.38 & PLUSMN;455.34, 222.77 & PLUSMN;98.04 and 194.54 & PLUSMN;61.19 ng, Tmax, ASA: 6.75(2,16), 4.5(2,11) and 8.25(5,11) h, T1/2, ASA: 0.43 & PLUSMN;0.08, 1.44 & PLUSMN;0.59 and 4.32 & PLUSMN;10.04 h, AUC0-t, ASA: 1008.88 & PLUSMN;452.27, 918.04 & PLUSMN;238.40 and 845.55 & PLUSMN;183.25 h & BULL;ng/mL; Cmax, SA: 6409.38 & PLUSMN;2098.52, 2863.53 & PLUSMN;679.73 and 2913.75 & PLUSMN;853.27ng/mL, Tmax, SA: 7.25(2,24), 10(3.5-14) and 10(7,14) h, T1/2, SA: 2.21 & PLUSMN;0.46, 2.69 & PLUSMN;0.72 and 3.51 & PLUSMN;2.06h, AUC0-t, SA: 29,131.41 & PLUSMN;9376.23, 27,243.97 & PLUSMN;7465.16, 27,240.25 & PLUSMN;7444.67 h & BULL;ng/mL. When taking EcSr aspirin tablets, the 90% confidence intervals of the geometric mean ratios (pre-prandial/post-prandial) of AUC0-t, ASA and AUC0-& INFIN;, ASA, Cmax, SA, AUC0-t, SA and AUC0-& INFIN;, SA were within the range of 80.00%-125.00%.Conclusion: EcSr aspirin tablets showed less inter-individual variation in release and absorption than Ec aspirin tablets, which was well reflected by comparing essential PK parameters. Furthermore, meals had no significant effect on the pharmacokinetics of EcSr aspirin tablets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据